Asimily’s KLAS Win Signals Shift to ROI-Driven Healthcare IoT Security
- Asimily scored 96.6/100 in the 2026 KLAS Healthcare IoT Security report, leading the field.
- 43% of North American hospital CISOs cited complete device visibility as their top challenge (Asimily 2025 research).
- KLAS report highlights shift from basic device discovery to measurable risk reduction and ROI in healthcare IoT security.
Experts agree that healthcare IoT security is evolving beyond basic visibility, with demand growing for platforms that deliver measurable risk reduction, operational efficiency, and clear ROI—Asimily’s KLAS win reflects this industry-wide shift.
Asimily’s KLAS Win Signals Shift to ROI-Driven Healthcare IoT Security
SUNNYVALE, CA – February 04, 2026 – In a significant affirmation from one of the healthcare industry's most trusted third-party evaluators, cybersecurity firm Asimily has secured the top performance score in the 2026 Best in KLAS Healthcare IoT Security report. The recognition, based on extensive interviews with healthcare providers, highlights a critical evolution in the sector: a pivot from basic device discovery to a demand for security platforms that deliver measurable risk reduction and a clear return on investment.
Asimily earned an overall score of 96.6 out of 100, leading a competitive field of vendors. The KLAS report, a benchmark for technology performance in healthcare, underscores a growing sophistication among hospital leaders who are no longer satisfied with simply knowing what devices are on their network. Instead, they are demanding actionable intelligence and streamlined workflows that strengthen their security posture without disrupting patient care.
From Expense to Investment: The New Calculus of Cybersecurity
For years, cybersecurity has been viewed as a necessary but costly expense. However, Asimily's top ranking in the “Money’s Worth” category suggests a fundamental change in perspective. As healthcare IT budgets face increasing pressure, chief financial and information officers are scrutinizing every dollar spent. The KLAS findings indicate that platforms providing demonstrable value and operational efficiency are rising above the noise.
According to customer feedback aggregated by KLAS, Asimily’s strength lies in its ability to move beyond colorful dashboards and into enforceable remediation. The platform was lauded for its capacity to not only identify vulnerabilities across the vast ecosystem of Internet of Medical Things (IoMT), Internet of Things (IoT), and Operational Technology (OT) devices, but to intelligently prioritize them based on clinical and business impact. This outcome-driven approach directly addresses a major pain point identified in Asimily's own 2025 research, which found that 43% of North American hospital CISOs cited complete device visibility as their most acute challenge, followed closely by internal process bottlenecks and data overload.
“Healthcare organizations depend on large, heterogeneous device fleets to deliver patient care,” said Shankar Somasundaram, CEO of Asimily, in a statement accompanying the announcement. “Device and equipment downtime is not an option, but neither is security. Healthcare leaders need solutions... that move them beyond visibility and into enforceable remediation and measurable risk reduction.”
This sentiment reflects a market that is maturing past foundational capabilities. Where device inventory was once the primary goal, it is now merely the starting point. The real value, as demonstrated by the KLAS report, is in what happens next: automating risk assessment, streamlining remediation tasks, and proving that security investments are actively reducing the organization's attack surface.
Bridging the Gap Between IT and the Bedside
One of the most significant, yet often overlooked, challenges in healthcare cybersecurity is the operational divide between Information Technology (IT), security, and clinical engineering teams. These groups often use different tools, speak different languages, and have different priorities. IT and security focus on network integrity and threat mitigation, while clinical engineers are responsible for the hands-on maintenance and uptime of patient care equipment. A security vulnerability in an infusion pump is both a network risk and a direct patient safety issue, requiring coordinated action.
Asimily’s high marks are attributed in part to its ability to serve as a Rosetta Stone for these disparate teams. Customers reported that the platform excels at not just identifying a risk but also routing the remediation task to the correct operational owner. This streamlined workflow ensures that a network-level issue is assigned to IT, while a device-specific vulnerability is directed to the biomedical team with the context they need to act.
By facilitating this collaboration, the platform helps break down the internal process silos that often hinder effective risk management. This empowers the “silent guardians” of healthcare—the clinical engineers and biomedical technicians—by providing them with the clear, prioritized intelligence needed to secure medical devices without becoming cybersecurity experts themselves. The result is a more cohesive security strategy that protects data, ensures device availability, and ultimately contributes to uninterrupted, high-quality patient care.
The Technical Blueprint for Cyber Resilience
Underpinning this success are two key technologies that the KLAS report identifies as top priorities for healthcare leaders: microsegmentation and AI-driven automation. These capabilities represent the next frontier in building robust cyber resilience for complex healthcare environments.
Microsegmentation is a security technique that involves breaking a network down into small, isolated zones. In a hospital setting, this could mean creating a separate network segment for all infusion pumps or imaging devices. If one device is compromised, microsegmentation contains the threat, preventing it from moving laterally across the network to infect other systems. Asimily’s platform provides the deep device intelligence required to create and enforce these granular segmentation policies, allowing hospitals to leverage their existing network infrastructure, such as Cisco ISE, more effectively.
AI-driven automation tackles the pervasive problem of data overload. A typical hospital network can generate millions of security alerts, overwhelming security teams and leading to alert fatigue. Asimily uses AI to analyze vulnerabilities, cross-reference them with device utilization and clinical context, and automatically prioritize the handful of threats that pose a genuine risk to the organization. This allows security and IT teams to focus their limited resources on what matters most, moving from a reactive to a proactive security posture.
Navigating a Crowded and Competitive Field
Asimily’s achievement is particularly notable given the highly competitive landscape of healthcare IoT security. The KLAS report evaluated several other prominent vendors, with Claroty (92.1) and Armis (91.1) also earning high marks as top performers. This healthy competition signifies a vibrant market where vendors are actively innovating to meet the evolving needs of healthcare providers.
Vendors like Claroty were praised for their usability and strong inventory management, while Armis was noted for its cost-effectiveness in large-scale deployments. The KLAS report suggests that the entire market is shifting, with all leading vendors working to provide solutions that connect device intelligence to tangible security outcomes. The days of standalone visibility tools are numbered, as customers now expect integrated platforms that support segmentation, automate remediation workflows, and integrate seamlessly with their broader security ecosystem, including SIEM and NDR systems.
This market-wide evolution, validated by the independent feedback of hundreds of healthcare professionals, confirms that the standard has been raised. Asimily's top ranking in 2026 sets a new benchmark, but it also illuminates the path forward for the entire industry—a path defined by operational alignment, measurable value, and an unwavering focus on protecting the technology that powers modern patient care.
